Cognition in myotonic dystrophy type 1: a 5‐year follow‐up study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Neurology

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ene.13062PMID 27323306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness

  2015cited by this paper
• When Does Cognitive Functioning Peak? The Asynchronous Rise and Fall of Different Cognitive Abilities Across the Life Span

  2015cited by this paper
• Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1.

  2014cited by this paper
• Cognitive Impairment in Myotonic Dystrophy Type 1 Is Associated with White Matter Damage

  2014cited by this paper
• Intellectual Functioning of Individuals with Mental Disorders on Wechsler Adult Intelligence Scale -Revised (WAIS -R)

  2011cited by this paper
• The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease

  2011cited by this paper
• The myotonic dystrophies: diagnosis and management

  2010influential reference
• Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA

  2009cited by this paper
• Cognitive impairment in myotonic dystrophy type 1 (DM1)

  2008cited by this paper
• Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1

  2008cited by this paper
• Cerebral involvement in myotonic dystrophies

  2007cited by this paper
• Cognitive impairment in adult myotonic dystrophies: a longitudinal study

  2007cited by this paper
• Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning.

  2006cited by this paper
• Practice effects and the use of alternate forms in serial neuropsychological testing.

  2005cited by this paper
• Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease

  2005cited by this paper
• Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1).

  2005cited by this paper
• A 5-year follow-up study of an atypical case of myotonic dystrophy

  2005cited by this paper
• Trail Making Test A and B: normative data stratified by age and education.

  2004cited by this paper
• Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

  2003cited by this paper
• Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples.

  2001cited by this paper
• Handbook of Normative Data for Neuropsychological Assessment

  2001cited by this paper
• Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy

  2001cited by this paper
• Discovering Statistics Using SPSS

  2000cited by this paper
• Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming.

  1999cited by this paper
• Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test.

  1999influential reference
• Cognitive function in myotonic dystrophy: a follow-up study.

  1993cited by this paper
• Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

  1992cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper

• Translational behavioral phenotypes in DMSXL mice for CNS manifestations of DM1.

  2026cites this paper
• Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1

  2025cites this paper
• Two distinct trajectories of brain volume loss in myotonic dystrophy type 1 via machine learning

  2025cites this paper
• Neuropsychological and behavioral outcomes in childhood-onset myotonic dystrophy type 1 through lifespan: a scoping review.

  2025cites this paper
• Neuroimaging in hereditary neuromuscular disorders: a literature review and clinical case reports

  2025cites this paper
• Multisystem Features in Adult-Onset Myotonic Dystrophy Type 1: An Integrative Case Analysis

  2025cites this paper
• Neural Damage and Inflammation in Myotonic Dystrophy Type 1: Longitudinal Analysis of Serum NFL, GFAP, and IL-6.

  2025cites this paper
• Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 1

  2024cites this paper
• Neurocognitive disorder in Myotonic dystrophy type 1

  2024cites this paper
• Myotonic dystrophy type 1 - a multiorgan disorder.

  2024cites this paper
• Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review

  2024cites this paper
• Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2

  2024cites this paper
• Neurobehavioral Phenotype of Children With Congenital Myotonic Dystrophy.

  2024cites this paper
• Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1—Results from a Retrospective Analysis in Italy

  2024cites this paper
• Common Characteristics Between Frailty and Myotonic Dystrophy Type 1: A Narrative Review

  2024cites this paper
• Do classical and computerized cognitive tests have equal intrarater reliability in myotonic dystrophy type 1?

  2023cites this paper
• 267th ENMC International workshop: psychological interventions for improving quality of life in slowly progressive neuromuscular disorders.

  2023cites this paper
• Sleep Disorders in Neuromuscular Diseases: A Narrative Review

  2023cites this paper
• Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study

  2023cites this paper
• Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1.

  2023cites this paper
• Gray Matter Abnormalities in Myotonic Dystrophy Type 1: A Voxel-Wise Meta-Analysis

  2022cites this paper
• A validated WAIS-IV short-form to estimate intellectual functioning in myotonic dystrophy type 1.

  2022cites this paper
• Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1.

  2022cites this paper
• Unravelling the impact of frontal lobe impairment for social dysfunction in myotonic dystrophy type 1

  2022cites this paper
• [Cognitive impairment in myotonic dystrophy type 1 (Steinert's disease)].

  2022cites this paper
• Explanatory factors of dynamic balance impairment in myotonic dystrophy type 1

  2022cites this paper
• Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1

  2022cites this paper
• Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow‐up study

  2022cites this paper
• Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer‐assisted evaluation

  2022cites this paper
• Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1

  2022cites this paper
• Alteración cognitiva en la distrofia miotónica tipo 1 (enfermedad de Steinert)

  2022cites this paper
• Cellular Senescence and Aging in Myotonic Dystrophy

  2022cites this paper
• Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy.

  2021cites this paper
• Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

  2021cites this paper
• New developments in myotonic dystrophies from a multisystemic perspective.

  2021cites this paper
• Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1

  2021cites this paper
• Neurodegeneration trajectory in pediatric and adult/late DM1: A follow‐up MRI study across a decade

  2020cites this paper
• The myotonic dystrophies

  2020cites this paper
• Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.

  2020cites this paper
• Myotonic dystrophy type 1 accompanied with normal pressure hydrocephalus: a case report and literature review

  2020cites this paper
• Recognition of emotions conveyed by facial expression and body postures in myotonic dystrophy (DM).

  2020cites this paper
• Mirtazapine: neuroprotection in a DM1 mouse model

  2020cites this paper
• Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement

  2020cites this paper
• Towards Central Nervous System Involvement in Adults with Hereditary Myopathies

  2020cites this paper
• Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis

  2020cites this paper
• Diagnosis of Myotonic Dystrophy Based on Resting State fMRI Using Convolutional Neural Networks

  2020cites this paper
• Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1

  2020cites this paper
• Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances

  2020cites this paper
• DNA methylation at the DMPK gene locus is associated with cognitive functions in myotonic dystrophy type 1.

  2020cites this paper
• A neurodevelopmental approach to myotonic dystrophy type 1

  2019cites this paper
• Cognitive and adaptive functioning in congenital and childhood forms of myotonic dystrophy type 1: a longitudinal study

  2019cites this paper
• Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

  2019cites this paper
• Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.

  2019cites this paper
• Look at the cognitive deficits in patients with myotonic dystrophy type 1: an exploratory research on the effects of virtual reality

  2019influential citation
• Clinical and genetic characteristics of childhood‐onset myotonic dystrophy

  2019cites this paper
• High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.

  2019cites this paper
• Myotonic Muscular Dystrophies.

  2019cites this paper
• Age‐related cognitive decline in myotonic dystrophy type 1: An 11‐year longitudinal follow‐up study

  2019cites this paper
• Differences in the pattern of cognitive impairments between juvenile and adult onset myotonic dystrophy type 1.

  2019cites this paper
• Advances in imaging of brain abnormalities in neuromuscular disease

  2019cites this paper
• Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1

  2019cites this paper
• Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study

  2019cites this paper
• Uncovering health and social care needs among myotonic dystrophy patients

  2019cites this paper
• Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.

  2018cites this paper
• Cognitive behavioural therapy with optional graded exercise therapy in severely fatigued patients with myotonic dystrophy type 1: a single-blind randomised trial

  2018cites this paper
• Cognitive impairment and quality of life in patients with myotonic dystrophy type 1

  2018cites this paper
• Clinical Features of the Central Nervous System

  2018cites this paper
• Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight

  2018cites this paper
• Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

  2018cites this paper
• Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy

  2018cites this paper
• Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

  2018cites this paper
• Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1

  2018cites this paper
• Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.

  2017cites this paper
• [Age-related cognitive decline in adults with DM1: a 9-year longitudinal study].

  2017cites this paper
• The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis.

  2017cites this paper
• Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2

  2017cites this paper
• Advances and insights into neurological practice 2016−17

  2017cites this paper
• Steinert syndrome and repercussions in dental medicine.

  2017cites this paper
• CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy

  2017cites this paper
• Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS

  2017cites this paper
• Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.

  2017cites this paper
• Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy

  2016cites this paper